Access the full text.
Sign up today, get DeepDyve free for 14 days.
F. Tonin, Inajara Rotta, Antonio Mendes, R. Pontarolo (2017)
Network meta-analysis: a technique to gather evidence from direct and indirect comparisonsPharmacy Practice, 15
A. Ismaila, K. Haeussler, A. Czira, J. Youn, M. Malmenäs, N. Risebrough, J. Agarwal, M. Nassim, Raj Sharma, C. Compton, C. Vogelmeier, M. Han, D. Halpin (2022)
Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-AnalysisAdvances in Therapy, 39
T. Siler, E. Kerwin, Karen Singletary, Jean Brooks, A. Church (2015)
Efficacy and Safety of Umeclidinium Added to Fluticasone Propionate/Salmeterol in Patients with COPD: Results of Two Randomized, Double-Blind StudiesCOPD, 13
P. Calverley, F. Martinez, J. Vestbo, C. Jenkins, R. Wise, D. Lipson, N. Cowans, J. Yates, C. Crim, B. Celli (2022)
International Differences in the Frequency of Chronic Obstructive Pulmonary Disease Exacerbations Reported in Three Clinical TrialsAmerican Journal of Respiratory and Critical Care Medicine, 206
(Dias S, Welton NJ, Sutton AJ, Caldwell DM, Lu G, Ades AE. NICE DSU Technical Support Document 4: Inconsistency in networks of evidence based on randomised controlled trials. 2011; last updated April 2014. http://www.nicedsu.org.uk. Accessed 3 Nov 2022.)
Dias S, Welton NJ, Sutton AJ, Caldwell DM, Lu G, Ades AE. NICE DSU Technical Support Document 4: Inconsistency in networks of evidence based on randomised controlled trials. 2011; last updated April 2014. http://www.nicedsu.org.uk. Accessed 3 Nov 2022.Dias S, Welton NJ, Sutton AJ, Caldwell DM, Lu G, Ades AE. NICE DSU Technical Support Document 4: Inconsistency in networks of evidence based on randomised controlled trials. 2011; last updated April 2014. http://www.nicedsu.org.uk. Accessed 3 Nov 2022., Dias S, Welton NJ, Sutton AJ, Caldwell DM, Lu G, Ades AE. NICE DSU Technical Support Document 4: Inconsistency in networks of evidence based on randomised controlled trials. 2011; last updated April 2014. http://www.nicedsu.org.uk. Accessed 3 Nov 2022.
R. Panettieri, Carlos Camargo, T. Cheema, S. Bayadi, S. Fiel, T. Vila, R. Jain, D. Midwinter, B. Thomashow, A. Ludwig-Sengpiel, D. Lipson (2022)
Effect of Recent Exacerbation History on the Efficacy of Once-Daily Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease in the FULFIL TrialInternational Journal of Chronic Obstructive Pulmonary Disease, 17
D. Hoaglin, N. Hawkins, J. Jansen, D. Scott, R. Itzler, J. Cappelleri, C. Boersma, D. Thompson, K. Larholt, M. Diaz, Annabel Barrett (2011)
Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 14 4
A. Bourdin, N. Molinari, G. Ferguson, Barinder Singh, M. Siddiqui, U. Holmgren, M. Ouwens, M. Jenkins, E. Nigris (2021)
Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol Fumarate versus Other Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysisAdvances in Therapy, 38
F. Maltais, G. Ferguson, G. Feldman, G. Deslée, A. Bourdin, H. Fjällbrant, Agnieszka Siwek-Posłuszna, M. Jenkins, U. Martin (2019)
A Randomized, Double-Blind, Double-Dummy Study of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Relative to Umeclidinium/Vilanterol Dry Powder Inhaler in COPDAdvances in Therapy
S. Dias, N. Welton, A. Sutton, D. Caldwell, G. Lu, A. Ades (2011)
NICE DSU Technical Support Document 4: Inconsistency in Networks of Evidence Based on Randomised Controlled Trials.
C. Poole, S. Greenland (1999)
Random-effects meta-analyses are not always conservative.American journal of epidemiology, 150 5
(Chaimani A, Caldwell DM, Li T, Higgins JPT, Salanti G. Chapter 11: Undertaking network meta-analyses. In: Higgins JPT, Thomas J, Chandler J, et al (editors). Cochrane handbook for systematic reviews of interventions. Version 6.3 (updated February 2022). Cochrane; 2022. https://training.cochrane.org/handbook.)
Chaimani A, Caldwell DM, Li T, Higgins JPT, Salanti G. Chapter 11: Undertaking network meta-analyses. In: Higgins JPT, Thomas J, Chandler J, et al (editors). Cochrane handbook for systematic reviews of interventions. Version 6.3 (updated February 2022). Cochrane; 2022. https://training.cochrane.org/handbook.Chaimani A, Caldwell DM, Li T, Higgins JPT, Salanti G. Chapter 11: Undertaking network meta-analyses. In: Higgins JPT, Thomas J, Chandler J, et al (editors). Cochrane handbook for systematic reviews of interventions. Version 6.3 (updated February 2022). Cochrane; 2022. https://training.cochrane.org/handbook., Chaimani A, Caldwell DM, Li T, Higgins JPT, Salanti G. Chapter 11: Undertaking network meta-analyses. In: Higgins JPT, Thomas J, Chandler J, et al (editors). Cochrane handbook for systematic reviews of interventions. Version 6.3 (updated February 2022). Cochrane; 2022. https://training.cochrane.org/handbook.
(ClinicalTrials.gov. A randomized, double-blind, parallel-group, 24-week, chronic-dosing, multi-center study to assess the efficacy and safety of PT010, PT003, and PT009 compared with Symbicort® Turbuhaler® (Kronos) (KRONOS); study results. https://clinicaltrials.gov/ct2/show/results/NCT02497001. Accessed 29 Sep 2022.)
ClinicalTrials.gov. A randomized, double-blind, parallel-group, 24-week, chronic-dosing, multi-center study to assess the efficacy and safety of PT010, PT003, and PT009 compared with Symbicort® Turbuhaler® (Kronos) (KRONOS); study results. https://clinicaltrials.gov/ct2/show/results/NCT02497001. Accessed 29 Sep 2022.ClinicalTrials.gov. A randomized, double-blind, parallel-group, 24-week, chronic-dosing, multi-center study to assess the efficacy and safety of PT010, PT003, and PT009 compared with Symbicort® Turbuhaler® (Kronos) (KRONOS); study results. https://clinicaltrials.gov/ct2/show/results/NCT02497001. Accessed 29 Sep 2022., ClinicalTrials.gov. A randomized, double-blind, parallel-group, 24-week, chronic-dosing, multi-center study to assess the efficacy and safety of PT010, PT003, and PT009 compared with Symbicort® Turbuhaler® (Kronos) (KRONOS); study results. https://clinicaltrials.gov/ct2/show/results/NCT02497001. Accessed 29 Sep 2022.
G. Ferguson, P. Darken, S. Ballal, M. Siddiqui, Barinder Singh, S. Attri, U. Holmgren, E. Nigris (2020)
Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysisAdvances in Therapy, 37
(Deeks JJ, Higgins JPT, Altman DG, on behalf of the Cochrane Statistical Methods Group. Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, et al (editors). Cochrane handbook for systematic reviews of interventions. Version 6.3 (updated February 2022). Cochrane; 2022. Available from https://training.cochrane.org/handbook.)
Deeks JJ, Higgins JPT, Altman DG, on behalf of the Cochrane Statistical Methods Group. Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, et al (editors). Cochrane handbook for systematic reviews of interventions. Version 6.3 (updated February 2022). Cochrane; 2022. Available from https://training.cochrane.org/handbook.Deeks JJ, Higgins JPT, Altman DG, on behalf of the Cochrane Statistical Methods Group. Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, et al (editors). Cochrane handbook for systematic reviews of interventions. Version 6.3 (updated February 2022). Cochrane; 2022. Available from https://training.cochrane.org/handbook., Deeks JJ, Higgins JPT, Altman DG, on behalf of the Cochrane Statistical Methods Group. Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, et al (editors). Cochrane handbook for systematic reviews of interventions. Version 6.3 (updated February 2022). Cochrane; 2022. Available from https://training.cochrane.org/handbook.
(2022)
Good publication practice (GPP) guidelines for company-sponsored biomedical research: 2022 updateAnn Intern Med, 175
(2006)
Cochrane Handbook for Systematic Reviews of Interventions Edited by Julian P. T. Higgins &
D. Lipson, H. Barnacle, R. Birk, N. Brealey, N. Locantore, D. Lomas, A. Ludwig-Sengpiel, R. Mohindra, M. Tabberer, Chang-Qing Zhu, S. Pascoe (2017)
FULFIL Trial: Once‐Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 196
S. Dias, D. Caldwell (2018)
Network meta-analysis explainedArchives of Disease in Childhood. Fetal and Neonatal Edition, 104
D. Lipson, F. Barnhart, N. Brealey, Jean Brooks, G. Criner, Nicola Day, M. Dransfield, D. Halpin, M. Han, Elaine Jones, S. Kilbride, P. Lange, D. Lomas, F. Martinez, Dave Singh, M. Tabberer, R. Wise, S. Pascoe (2018)
Once‐Daily Single‐Inhaler Triple versus Dual Therapy in Patients with COPDThe New England Journal of Medicine, 378
E. Ahn, Hyun Kang (2021)
Concepts and emerging issues of network meta-analysisKorean Journal of Anesthesiology, 74
P. Rogliani, J. Ora, F. Cavalli, M. Cazzola, L. Calzetta (2022)
Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS ScoreJournal of Clinical Medicine, 11
S. Attia (2020)
Systematic Literature ReviewLiterature Reviews
A. Sousa, J. Riley, A. Church, Chang-Qing Zhu, Y. Punekar, W. Fahy (2016)
The effect of umeclidinium added to inhaled corticosteroid/long-acting β2-agonist in patients with symptomatic COPD: a randomised, double-blind, parallel-group studyNPJ Primary Care Respiratory Medicine, 26
G. Ferguson, K. Rabe, F. Martinez, L. Fabbri, Chen Wang, M. Ichinose, E. Bourne, S. Ballal, P. Darken, K. DeAngelis, M. Aurivillius, P. Dorinsky, C. Reisner (2018)
Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial.The Lancet. Respiratory medicine, 6 10
L. DeTora, T. Lane, A. Sykes, Faith DiBiasi, D. Toroser, L. Citrome (2023)
Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 UpdateAnnals of Internal Medicine, 176
Benjamin Rouse, A. Chaimani, Tianjing Li (2017)
Network meta-analysis: an introduction for cliniciansInternal and Emergency Medicine, 12
J. Higgins, D. Jackson, J. Barrett, G. Lu, A. Ades, Ian White (2012)
Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies‡Research Synthesis Methods, 3
J. Deeks, J. Higgins, D. Altman (2019)
Analysing data and undertaking meta‐analysesCochrane Handbook for Systematic Reviews of Interventions
A. Chaimani, D. Caldwell, Tianjing Li, J. Higgins, G. Salanti (2019)
Undertaking network meta‐analysesCochrane Handbook for Systematic Reviews of Interventions
A. Chaimani (2018)
Chapter 11 : Undertaking network meta-analyses
Hyun Lee, Hyung-Jun Kim, E. Jang, Chang-Hoon Lee (2021)
Comparisons of Efficacy and Safety between Triple (Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting Beta-Agonist) Therapies in Chronic Obstructive Pulmonary Disease: Systematic Review and Bayesian Network Meta-AnalysisRespiration, 100
J. Jansen, T. Trikalinos, J. Cappelleri, Jessica Daw, S. Andes, R. Eldessouki, G. Salanti (2014)
Indirect treatment comparison/network meta-analysis study questionnaire to assess relevance and credibility to inform health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17 2
J. Hurst, M. Han, Barinder Singh, Sanjeev Sharma, Gagandeep Kaur, E. Nigris, U. Holmgren, M. Siddiqui (2022)
Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature reviewRespiratory Research, 23
Adv Ther https://doi.org/10.1007/s12325-023-02491-4 LETTER Letter to the Editor Regarding ‘‘Fluticasone Furoate/ Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis’’ . . . Jonathan Marshall Akanksha Sharma Patrick Darken . . Mario Ouwens Barinder Singh Deniz Tansey-Dwyer Received: November 15, 2022 / Accepted: March 9, 2023 The Author(s) 2023 Heterogeneity between studies was not Keywords: COPD; Indirect treatment adequately accounted for; only results comparison; Network meta-analysis; Triple from a fixed-effects model are reported, therapy which contradicts guidance on NMA methodology for comparing studies with considerable heterogeneity and can yield Key Summary Points misleading results. The network meta-analysis (NMA) of Due to fundamental differences between Ismaila et al. contains limitations in the FULFIL and KRONOS studies, and a design and reporting that could strongly single common comparator that influence the validity of the findings and performed differently in the two studies, conclusions. these should not have been relied upon to establish a network connection to compare fluticasone furoate/ J. Marshall (&) D. Tansey-Dwyer umeclidinium/vilanterol (FF/UMEC/VI) AstraZeneca, Academy House, 136 Hills Road, and budesonide/glycopyrronium Cambridge CB2 8PA, UK bromide/formoterol fumarate (BUD/GLY/ e-mail: jonathan.marshall1@astrazeneca.com FOR). D. Tansey-Dwyer e-mail: deniz.tansey-dwyer@astrazeneca.com Given these methodological issues and
Advances in Therapy – Springer Journals
Published: Apr 1, 2023
Keywords: COPD; Indirect treatment comparison; Network meta-analysis; Triple therapy
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.